P
The startup has developed an in-silico drug design platform that utilizes protein folding algorithms, artificial intelligence, and molecular dynamics simulations to enhance the drug discovery process. This technology addresses the limitations of traditional rigid protein-ligand docking models, enabling researchers to more efficiently identify specific drug candidates.
Busan, South Korea
Updated 2 months ago
Funding
$22.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed an in-silico drug design platform that utilizes protein folding algorithms, artificial intelligence, and molecular dynamics simulations to enhance the drug discovery process. This technology addresses the limitations of traditional rigid protein-ligand docking models, enabling researchers to more efficiently identify specific drug candidates.